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1. Introduction 
Enantioselective alkene epoxidation catalyzed by chiral ketones, using Oxone as 
stoichiometric oxidant, has been intensively studied over the past decade and has resulted in 
the design of several effective novel ketone architectures.1,2 In particular, a comprehensive 
series of inventive contributions from Shi and co-workers has demonstrated chiral ketones 
derived from carbohydrates to be exceptionally selective and practical members of the 
asymmetric synthesis toolbox.1,3-5 The fructose-derived ketone 1 is now widely employed for 
the epoxidation of trans- and trisubstituted alkenes. Interestingly, Shi has extended the 
applicability of his catalysts to a wide range of alkene substitution patterns, including 
challenging terminal olefins,5 by modifying the catalyst structure. Catalysts 2 incorporating a 
fused spirocyclic oxazolidinone moiety have been especially effective for this purpose, and 
several interesting electronic effects have been noted upon variation of the oxazolidinone N-
substituent.4 As well as their synthetic utility, chiral ketone catalysts have provided 
outstanding insights into the mechanisms of asymmetric induction with computational studies 
providing satisfying agreement with experimental data.6  
                                                          
†
 With congratulations to Prof. Steve Ley on the award of the Tetrahedron Prize.  
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In our own work, we have introduced 2-substituted-bicyclo[3.2.1]octanones 3 as a family of 
chiral catalysts which are generally stable to Baeyer-Villiger reaction,7 allowing the 
development of solid supported variants.7c Good-to-excellent enantioselectivities (up to 98% 
ee) have been obtained for trans- and trisubstituted olefins, but generally poor results for 
terminal alkenes. Nevertheless, the enantioselectivities afforded are notable given the simple 
nature of the ketone alpha-substituents (e.g. Y=F or OAc). In view of the remarkable 
effectiveness and tunability of the alpha-oxazolidinone-bearing spirocyclic systems 
developed by Shi, we were keen to incorporate this more complex motif onto our own 
bicyclic system. In addition, we reasoned that the markedly different synthetic routes 
available for catalyst synthesis from non-carbohydrate precursors might allow access to novel 
spirocyclic moieties that have not previously been explored. The synthesis of several novel 
catalysts of this type (4-6) and their effectiveness for enantioselective epoxidation of a range 
of alkenes is reported herein. A new alternative spirocycle, the sulfamidate unit, is also 
prepared and tested.  
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2. Results and Discussion 
2.1 Catalyst synthesis 
Our previous studies on bicyclo[3.2.1]octanone catalysts7 employed chiral base-mediated 
desymmetrisation of the parent ketone 7 to access enantiomerically enriched material. This 
approach relied on enantiomeric enrichment by recrystallisation for access to 
enantiomerically pure catalysts. In the present study, we prepared catalysts initially in 
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racemic form and resolved them on a chiral stationary phase (vide infra) to facilitate catalyst 
screening. We identified enone 8 as a key potential intermediate for the synthesis of a wide 
range of our target spirocyclic ketones. We have previously reported a synthesis of 8 from 
commercially available 7.7d However, we were keen to develop a superior route since the 
earlier approach, involving cyclopropanation of the trimethylsilyl enol ether of 7, was quite 
lengthy and low yielding (33% from 7). A better approach was found to involve silyl enol 
ether formation and reaction with Eschenmoser’s salt, followed by N-quaternization and 
base-mediated elimination (Scheme 1).8 After some experimentation to identify optimal 
conditions, the process provided reproducible yields of ca. 60% of 8, with the main side-
product (10-20%) being dienone. We have previously reported7d dihydroxylation of 8 to give 
diol 9; the derived acetonide was found to be a poor epoxidation catalyst, undergoing 
decomposition by Baeyer-Villiger reaction. We reasoned that the corresponding carbonate 4 
would be less susceptible to this side-reaction, and would present a novel spirocyclic motif 
not tested in the Shi systems. Treatment of 9 with triphosgene yielded racemic 4 (Scheme 1).  
 
 
 
Scheme 1: (a) ( i) LiHMDS, THF, -78 ºC; (ii) TMSCl, -78 ºC; (b) (i) Eschenmoser’s salt (Me2NCH2I), DMF, 
RT, 1.5 h; (ii) MeI, 50 ºC, sealed tube; (iii) NaHCO3, DMF, 95 ºC, 60-65%. (c) K2OsO4·2H2O, quinuclidine, 
NMO, acetone / H2O, 86%; (d) triphosgene, pyridine, DCM, 60%. 
 
For the synthesis of further fused heterocycles including oxazolidinones, epoxidation of 8 
followed by ring opening with an appropriate nucleophile was an attractive strategy. 
However, attempts to effect direct epoxidation of 8 were generally low yielding and afforded 
mixtures of diastereomers. While diol 9 could be converted cleanly to the diastereomerically 
pure ketoepoxide, exploratory experiments indicated that some of the later ketone 
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intermediates in this synthetic route were unstable. The ketone was therefore temporarily 
reduced by Luche reduction9 of 8 to give the allylic alcohol followed by epoxidation with m-
CPBA; the sequence occurred stereoselectively to afford 10 as confirmed by nOe studies. 
Epoxide 10 could then be opened by nucleophilic addition of several primary amines at the 
less hindered carbon to give amino alcohols 11 (Scheme 2). The regiochemical outcome of 
the epoxide opening was confirmed in one case (11d, R=Bn) by HMBC studies, notably a 3-
bond correlation between the benzylic protons and the CH2 carbon of the amino alcohol 
moiety. The other examples were assumed to follow the same regiochemical outcome. Since 
attempts to selectively engage the tertiary alcohol and amine in oxazolidinone formation with 
triphosgene proved problematic, we sought to oxidize the secondary alcohol group first. 
Several common methods (TPAP, PCC, Jones or Dess-Martin reagents) proved unsuccessful. 
An effective method was eventually found to be the use of IBX in the presence of acid 
(TFA),10 under which conditions protonation of the amino group is presumed to protect it 
from oxidation. Attempts to use this route to prepare 5g (R = Ph) failed at the IBX oxidation 
step: as an alternative, the Swern oxidation was successful in this case. Finally, cyclisation 
with triphosgene in pyridine afforded ketones 5. Where a chiral, enantiomerically pure amine 
(S-α-methyl benzylamine) was used in the epoxide opening step, the final product was 
obtained as a mixture of two separable diastereomers, the configuration of one of which (5e) 
was determined by X-ray crystallography (vide infra).  
 
 
 
Scheme 2 (a) NaBH4, CeCl3·7H2O, MeOH, 0 ºC, 95%; (b) m-CPBA, DCM, 0 ºC, 70%; (c) RNH2 (1 eq), EtOH, 
80 ºC; (d) For 11a-f: IBX, TFA, DMSO. For 11g: (COCl)2, DMSO, then Et3N; (e) triphosgene, pyridine, DCM.  
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We wished to evaluate the steric and electronic effects of replacing the oxazolidinone 
nitrogen with a tetrahedral carbon atom. The required lactone was prepared as shown in 
Scheme 3. Silylation of epoxy alcohol 10 was followed by epoxide opening with the anion of 
diethyl malonate and concomitant lactonization and desilylation. Krapcho decarboxylation 
followed by TPAP oxidation12 of the secondary alcohol 12 delivered the target racemic 
ketone 6. 
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Scheme 3: (a) Et3N, TMSOTf, DCM, -78 ºC→-30 ºC, quantitative. (b) (i) NaH, diethyl malonate, THF; (ii) 
NaCl, DMSO, H2O, 150 °C, 35%. (c) TPAP, NMO, DCM, 53%. 
 
Finally, we decided to investigate the effect of replacing the oxazolidinone carbonyl with 
SO2. To the best of our knowledge, ketones bearing the spirocyclic cyclic sulfate or 
sulfamidate motif have not previously been tested in asymmetric epoxidation. The former 
was found to be too unstable under the Oxone epoxidation conditions to allow proper 
evaluation. The cyclic sulfamidate 14 was prepared from the amino alcohol 13, an 
intermediate in the synthesis of oxazoidinone 5a, by reaction with thionyl chloride followed 
by oxidation (Scheme 4). 
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Scheme 4: (a) SOCl2, pyridine, DCM, 48%; (b) RuCl3xH2O, NaIO4, CH3CN, H2O, 55%. 
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With the exception of 5e/5f derived from α-methyl benzylamine, all catalysts in Schemes 1-4 
were prepared as racemates. These were resolved by supercritical fluid chromatography 
(SFC) on chiral stationary phases to give enantiomerically pure catalysts for testing. The 
relative configuration of 5e was confirmed by X-ray crystallography (vide infra), and the 
absolute configuration for the other ketones was assigned based on correlation of the results 
for asymmetric epoxidation of E-stilbene (see later discussion). Overall, we have developed a 
versatile, 6-step approach from commercially available N-carbethoxytropinone 7 which offers 
the great advantage of reacting the advanced intermediate epoxide 10 with various 
nucleophiles at a late stage, thus allowing ready access to a wide range of substituted 
derivatives. The route could potentially be rendered enantioselective by desymmetrisation of 
7 using, for example, deprotonation with chiral bases, as in our earlier work.7 
 
2.2 Catalyst Evaluation 
Catalyst screening under standard Oxone/NaHCO3/CH3CN/H2O conditions13 began with E-
stilbene as test substrate, since this would allow comparison to results with our earlier 
catalysts. As a benchmark, the fluoroketone 3 (X=NCO2Et, Y=F) has been reported to 
epoxidize E-stilbene with 76% ee.7d The carbonate 4 was screened first (Table 1, entry 1). 
Complete conversion was observed using 10 mol% of 4, and the epoxide was obtained in 
excellent ee (87%). Similar results were obtained with the opposite catalyst enantiomer (entry 
2). Turning to the oxazolidinone catalysts, the NMe derivative 5a was screened first. 
Although a small decrease in conversion was noted, this catalyst displayed a slightly higher 
enantioselectivity (91.5% ee, entries 3 and 4). The effect of increased steric hindrance in the 
N-substituent was now probed. Moving to N=iPr derivative 5b resulted in a slight drop in 
conversion and enantioselectivity (entry 5), while the NtBu analog 5c performed more poorly 
in both regards (entry 6). The NBn counterpart 5d provided similar results (entry 7), with 
incomplete conversion even at 20 mol% loading, suggesting that this substituent does not 
provide beneficial aromatic-aromatic interactions with the alkene substrate. The related 
catalysts 5e and 5f provided an interesting test of the effect of an additional element of central 
chirality. The former performed better both in terms of conversion and enantioselectivity (87 
vs 69% ee, entries 9 and 10). The final derivatives tested in Table 1 (entries 11-14), whilst 
showing variations in reactivity, displayed remarkably similar levels of enantioselectivity. 
Indeed, the five catalysts 4, 5a, 5g, 6, 14, with cyclic carbonate, N-methyl- and N-phenyl 
oxazolidinone, lactone and sulfamidate spiro systems all afforded E-stilbene oxide in the 
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narrow range of 87-91.5% ee. This suggests that in this catalyst family, specific interactions 
with particular elements of the spirocycle are not significant factors in controlling 
enantioselectivity.  
In each case, the enantiomer of the ketone catalyst that afforded (R,R)-stilbene oxide was 
assigned the configuration depicted in the Schemes based on the well established spiro-TS 
model1, 6 in Figure 1 which has been found to operate with our previous related catalysts.7 In 
the case of 5e, the catalyst configuration was confirmed by X-ray crystallography. In this 
crystal structure (Figure 2), 5e adopts a conformation in which the benzylic hydrogen almost 
eclipses the oxazolidinone carbonyl. This places the Me-substituent towards the catalyst 
region approached by the olefin in the epoxidation TS. If the diastereomer 5f adopts a similar 
conformation, this would place the Ph-substituent in this position, with a resulting steric clash 
with the incoming olefin, offering a possible explanation for the lower reactivity and 
enantioselectivity observed for this catalyst. Similar steric interactions may account for the 
slightly lower ee value obtained with the NtBu catalyst ent-5c (entry 6).  
 
 
Figure 1: Epoxidation TS model 
 
 
 
Figure 2: The molecular structure of one of the two crystallographically independent 
molecules present in the crystals of 5e.11 
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Table 1: Catalytic Asymmetric Epoxidation of E-Stilbenea 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Epoxide 
Configurationd 
1 4 O 18 100 85 87 (R,R) 
2 ent-4 O 18 100 83 89 (S,S) 
3 5a N-Me 12 87 85 91.5 (R,R) 
4 ent-5a N-Me 12 86.5 85 91.5 (S,S) 
5 5b N-iPr 18 90 90 87 (R,R) 
6 ent-5c N-tBu 18 41 41 79 (S,S) 
7 ent-5d N-Bn 24 37 17 82 (S,S) 
8 ent-5db N-Bn 18 50 50 82 (S,S) 
9 5e (S)-NCH(CH3)Ph 12 52 50 87 (R,R) 
10 5f (S)-NCH(CH3)Ph 12 24 20 69 (S,S) 
11 5g N-Ph 12 76 74 87 (R,R) 
12 ent-5g N-Ph 12 69 68 88 (S,S) 
13 6 CH2 24 95 nd 90 (R,R) 
14 14 SO2 8 95 nd 87 (R,R) 
aConditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10 mol%). b catalyst (20% mol). cEstimated from the 1H NMR 
spectrum of the crude reaction mixture. d Product ee and configuration determined by chiral HPLC analysis. 
 
A selection of the catalysts was screened with two other trans-disubstituted olefins. With E-
β-methyl styrene (Table 2), the NMe-derivative 5a afforded best results (73.5% ee, entry 2). 
Catalysts with distinct cyclic motifs were again found to afford epoxides in a narrow range of 
enantioselectivity (compare entries 1, 3, 6 and 7). Cinnamate esters represent more 
challenging, less reactive substrates, the epoxides of which are synthetically useful. While 
moderate conversions were obtained, promising levels of enantioselectivity were observed 
(up to 82% ee, Table 3). For both of these trans-disubstituted substrates, the major epoxide 
enantiomer obtained is again consistent with the model in Figure 1.  
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Table 2: Catalytic Asymmetric Epoxidation of E-β-Methylstyrenea 
 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Epoxide 
Configurationd 
1 ent-4 O 1 100 25 63 (S,S) 
2 5ab N-Me 18 100 71 73.5 (R,R) 
3 5bb N-iPr 18 95 53 62 (R,R) 
4 ent-5db N-Bn 15 83 69 45 (S,S) 
5 5eb (S)-NCH(CH3)Ph 18 85 70 57 (R,R) 
6 ent-5gb N-Ph 18 96 90 64 (S,S) 
7 ent-6 CH2 8 100 nd 67 (S,S) 
a
 Conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10% mol). b Reaction conditions: alkene (0.2 mmol), Oxone® 
(2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution). c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration 
determined by chiral HPLC analysis. 
 
Table 3. Catalytic Asymmetric Epoxidation of E-Ethyl Cinnamatea 
 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Epoxide 
Configurationd 
1 ent-4 O 18 55 48 74 (2R,3S) 
2 5ab N-Me 18 44 41 80 (2S,3R) 
3 ent-5a N-Bn 15 20 17 61 (2R,3S) 
4 5b (S)-NCH(CH3)Ph 18 28 21 73 (2S,3R) 
5 ent-5db N-Ph 18 40 35 82 (2R,3S) 
6 ent-6 CH2 18 23 nd 78 (2R,3S) 
7 ent-14 SO2 18 17 nd 81 (2R, 3S) 
a
 Conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10% mol b Reaction conditions: alkene (0.2 mmol), Oxone® (2.0 
mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution).c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration 
determined by chiral HPLC analysis. 
 
Phenylcyclohexene has proved to be a particularly interesting substrate in epoxidation 
reactions with Shi’s carbohydrate-derived catalysts. The first generation catalyst 1 afforded 
(R,R)-phenyl cyclohexene oxide in excellent ee. This sense of selectivity is in accord with the 
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spiro-TS model similar to that shown in Figure 1. However, Shi has reported a reversal of 
enantioselectivity for some N-aryl- and N-Boc-oxazolidinone-containing spirocyclic ketones 
(e.g. 15, Figure 3).4 This was attributed to an attractive interaction between the oxazolidinone 
N-substituent and the phenyl ring on the alkene, resulting in predominant reaction via a 
planar-TS. With our own catalysts (Table 4), the major enantiomer was in all cases in accord 
with the spiro-TS-model (cf. Figure 1), suggesting that attractive interactions between the 
substrate-phenyl and our own spirocyclic substituents do not exert a significant influence.  
 
Figure 3: Enantiomeric excesses for epoxidation of phenyl cyclohexene with ketones 1 and 15  
 
Table 4: Catalytic Asymmetric Epoxidation of 1-Phenylcyclohexenea 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee (%)d Epoxide 
Configurationd 
1 ent-4 O 1 98 63 73 (S,S) 
2 5ab N-Me 18 100 65 74 (R,R) 
3 5bb N-iPr 1 95 54 71 (R,R) 
4 ent-5db N-Bn 15 100 58 51 (S,S) 
5 5eb (S)-NCH(CH3)Ph 18 100 69 64 (R,R) 
6 ent-5gb N-Ph 18 100 86 58 (S,S) 
7 6 CH2 8 88 nd 45 (R,R) 
8 14 SO2 8 65 nd 69 (R,R) 
a
 Conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10% mol). b Reaction conditions: alkene (0.2 mmol), Oxone® 
(2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution). c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration 
determined by chiral HPLC analysis. 
 
Direct enantioselective epoxidation of terminal alkenes remains an important challenge, and 
the highly encouraging results reported by Shi with his spirocyclic ketones5 prompted us to 
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screen our own catalysts. Epoxidation of styrene with fluoroketone 3 (X=NCO2Et, Y=F) 
affords styrene oxide in poor ee (29%).7d The majority of the new catalysts improve on this 
(Table 5), with 5f again affording lower enantioselectivity than its diastereomer 5e (entries 6 
and 7). The best result (59% ee) was with the NPh-derivative 5g (entry 8), suggesting that 
exploration of the effect of substituents on the catalyst’s aromatic ring may be worthwhile. 
Finally, the particularly challenging 1,1-disubstituted alkene class was examined (Table 6), 
but enantioselectivities were poor, and again within a relatively narrow range, suggesting an 
absence of specific TS-interactions between the various spirocyclic substituents and the 
alkene.  
 
Table 5: Catalytic Asymmetric Epoxidation of Styrenea 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Epoxide 
Configurationd 
1 ent-4 O 1 100 nd 46 (S) 
2 5ab N-Me 12 100 79 58 (R) 
3 5bb N-iPr 18 88 35 54 (R) 
4 ent-5cb N-tBu 18 >30 8 43 (S) 
5 ent-5db N-Bn 24 89 68 43 (S) 
6 5eb (S)-NCH(CH3)Ph 12 94 66 55 (R) 
7 5fb (S)-NCH(CH3)Ph 12 63 40 27 (S) 
8 ent-5gb N-Ph 24 93 29 59 (S) 
9 ent-6 CH2 18 100 nd 50 (S) 
a
 Conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10% mol). b Reaction conditions: alkene (0.2 mmol), Oxone® 
(2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution). c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration 
determined by chiral HPLC analysis.  
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Table 6. Catalytic Asymmetric Epoxidation of α-Methylstyrenea 
Entry Catalyst X t(h) Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Epoxide 
Configurationd 
1 ent-4b O 1 100 30 19 (S) 
2 5ab N-Me 12 100 90 17 (R) 
3 5bb N-iPr 10 100 27 15 (R) 
4 ent-5cb N-tBu 18 55 45 16 (S) 
5 ent-5db N-Bn 18 81 49 6 (S) 
6 5eb (S)-NCH(CH3)Ph 24 69 67 13 (R) 
7 ent-5gb N-Ph 24 97 52 12 (S) 
8 6 CH2 8 81 nd 13 (R) 
a
 Conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mM solution), catalyst (10% mol). b Reaction conditions: alkene (0.2 mmol), Oxone® 
(2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution). c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration 
determined by chiral HPLC analysis. 
 
3. Conclusions 
We have developed an efficient synthetic approach to a range of spirocyclic ketones which 
has allowed access to a several novel derivatives from a common synthetic intermediate. 
These new ketones are efficient catalysts for alkene epoxidation using Oxone, and can be 
used at low loadings (10 mol%). Enantioselectivities are very good for epoxidation of E-
stilbene, and the new spirocyclic catalysts afford higher ee for epoxidation of styrene than 
does the simpler ketone 3. The results for epoxidation of phenylcyclohexene, and the 
generally low variation of product ee with catalyst substitution, suggest that specific 
interactions with the spirocyclic substituents are not significant contributors to the observed 
enantioselectivities. Synthesis of a wider range of ketones, including more highly substituted 
variants, are ongoing and will be reported in due course.  
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4. Experimental 
4.1 General details 
All reactions requiring dry or inert conditions were conducted in oven-dried equipment under 
an atmosphere of nitrogen. Syringes and needles were oven-dried. Anhydrous THF, DMF, 
Et2O and MeOH were purchased from Aldrich Chemical Co. All commercially reagents were 
used without further purification. Flash chromatography was performed on silica gel Merck 
Kieselgel (230-400) mesh or on Varian Mega Be-Si pre-packed cartridges or on pre-packed 
Biotage silica cartridges. In a number of preparations, purification was performed using either 
Biotage manual flash chromatography (Flash+) or automatic flash chromatography (Horizon, 
SP1) systems. All these instruments work with Biotage Silica cartridges. 
SPE-SCX cartridges are ion exchange solid phase extraction columns supplied by Varian. 
The eluent used with SPE-SCX cartridges is methanol followed by 2 M ammonia solution in 
methanol. 
In a number of preparations, “dried” refers to a solution dried over anhydrous sodium sulfate 
(when organic solvents as diethyl ether or ethyl acetate are used) or by phase separator 
cartridge (when DCM is used). Phase separation cartridges were supplied by Whatman 
(PTFE, 5 µM pore size). 
Thin layer chromatography (TLC) was carried out on Merck 5×10 cm plates with silica gel 
60 F254 as sorbant. Visualisation of reaction components was achieved with UV lamp (254 
nm) and with ceric ammonium nitrate or potassium permanganate stains. Preparative thin 
layer chromatography was carried out using 20×20 cm silica gel GF tapered plates supplied 
by Analtech Inc, Newark. IR spectra were recorded on a Perkin-Elmer FT-IR spectrometer, 
Spectrum 1000 or on Nicolet FT-IR Magna 760 spectrometer. Samples were run as thin films 
(produced by the evaporation of chloroform or DCM) on aluminium oxide plates or on nujol. 
Absorption maxima are reported in wavenumber (cm-1). 
1H and 13C NMR spectra were recorded in CDCl3 unless stated otherwise on either a Bruker 
spectrometer at 500, 400 or 360 MHz, or on Varian instruments at 300, 400 or 500 MHz. 
Chemical shifts are reported in parts per million (δ) downfield from tetramethylsilane as 
internal standard and coupling constants are quoted in Hertz (Hz). Splitting patterns are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br) 
and combinations of the above. The NMR spectra were recorded at a temperature ranging 
from 25 to 90ºC.  
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Mass spectra were recorded using a HP1100 flow inject system (50:50 1% formic acid-
H2O:CH3CN) into an electrospray source of a Waters ZMD2000 or on a 4 II triple 
quadrupole Mass Spectrometer (Micromass UK) or on a Agilent MSD 1100 Mass 
Spectrometer, operating in ES (+) and ES (-) ionization mode. Accurate mass was recorded 
using a HP1100 flow injection into an electrospray source of a Waters Q-Tof micro or a 
Waters LCT Premier mass spectrometer equipped with a Z-spray source and coupled to a 
Waters UPLC (Ultra Performance Liquid Chromatography). Leucine Enkephalin was used as 
external standard and infused with a reference probe. Optical rotations were recorded on a 
Perkin-Elmer Polarimeter 241, with a path length of 5 cm or on a Optical-Activity AA-5 
Polarimeter with a path length of 5 cm, in chloroform or methanol. [α]D values are given in 
10-1 deg cm2 g-1. Concentrations (c) are given in grams per 100 cm3. Melting points were 
obtained using a Buchi melting point B-540 hot stage apparatus or a Gallenkamp melting 
point apparatus and are quoted as uncorrected. 
Separations of racemic ketones into single enantiomers were performed using Supercritical 
Fluid Chromatography (Chiralpak IA, Chiralpak AS or AS-H, Chiralpak AD-H column) on a 
Berger Minigram system with UV/VIS detector at 220 nm using CO2/methanol as mobile 
phase. Alternatively, they were performed by chiral chromatography (Chiralpak AS-H, ACE 
C8, Chiralpak AD-H or Chiralcel OJ-H column) on an Agilent HP1100 system with UV/VIS 
detector at 254 or 220 nm using iso-propanol/n-hexane or methanol/n-hexane as eluent; 
retention times are quoted in minutes. The absolute configuration of the ketones was assumed 
based on the observed major enantiomer of E-stilbene oxide obtained when they were used as 
catalysts, i.e. the catalyst enantiomers depicted in the Schemes give (R,R)-stilbene oxide, 
whilst the ent-series gives (S,S)-stilbene oxide. This is consistent with the spiro-TS model in 
Figure 1, with the results for earlier catalysts,7 and was confirmed by X-ray crystallography 
in the case of 5e.11  
Epoxide enantiomeric excesses (ee) were determined by chiral HPLC HP 1100 (Chiralpak 
AS, Chiralcel OD or Chiralcel OJ-H column) on an Agilent HP1100 system with UV/VIS 
detector at 254 or 220 nm using iso-propanol/n-hexane or methanol/n-hexane as eluent.  
 
4.2 Synthesis of Ketone Catalysts 
(1R*,5S*)-Ethyl 2-methylene-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate (±8). Under 
a nitrogen atmosphere, LiHMDS 1.0 M in THF (83 ml, 0.08 mol) was added dropwise to a 
stirred solution of ketone 7 (15.0 g, 0.08 mol) in THF (150 ml) cooled at -78 oC. After stirring 
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at -78 oC for 30 minutes, Me3SiCl (14.4 ml, 0.11 mol) was added, and stirring was continued 
for ½ hour. The reaction mixture was quenched with a saturated solution of NH4Cl (50 ml) at 
0 oC; then the organic layer was diluted with EtOAc (100 ml) and extracted with EtOAc (3× 
20 ml). The combined organics were washed with a saturated solution of NaHCO3 (50 ml), 
dried over MgSO4 and concentrated. The crude silyl enol ether intermediate was dissolved in 
DMF (150 ml), under a nitrogen atmosphere, and Eschenmoser’s salt (15.4 g, 0.08 mol) was 
added. The reaction mixture was stirred at room temperature for 1.5 hour and then MeI (23 
ml, 0.38 mol) was added. After stirring at 50 oC overnight in a sealed tube, NaHCO3 (47.0 g, 
0.56 mol) was added and the reaction mixture diluted with DMF (100 ml). It was heated to 95 
oC overnight and then cooled to room temperature, diluted with EtOAc (100 ml), washed 
with H2O (50 ml), extracted with EtOAc (3× 30 ml) and separated. The combined organics 
were dried over MgSO4 and concentrated. The residue was purified by flash chromatography 
over silica gel eluting with 25% EtOAc in n-hexane to give (±)-8 as a colourless oil (10.1 g, 
63%); νmax/cm-1 (CHCl3): 2977, 1693, 1622, 1410, 1380, 1106, 946, 768; 1H NMR δH (ppm) 
(CDCl3, 500 MHz): 5.91 (1 H, s, C=CH2), 5.24 (1 H, br s, C=CH2), 4.91 (1 H, br s, NCHC), 
4.57 (1 H, br s, NCHCH2CO), 4.18-4.14 (2 H, q, J = 7.1 Hz, OCH2CH3), 2.78 (1 H, br s, 
CHCH2axCO), 2.46 (1 H, d, J = 18.0 Hz, CHCH2eqCO), 2.29-2.17 (2 H, m, 
CHCH2exoCH2exoCH), 1.80-1.68 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 198.5 (C, C=Oketone), 154.0 (C, 
C=Ocarbamate), 146.8 (C, C=CH2), 119.6 (CH2, C=CH2), 61.8 (CH2, OCH2CH3), 58.6 (CH, 
NCHC), 52.8 (CH, NCHCH2CO), 47.9 (CH2, CHCH2CO), 31.4 (CH2, CHCH2CH2CH), 29.5 
(CH2, CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z (ES+) 210 ([M+H]+, 100%); m/z (ES+) 
found: [M+H]+, 210.1138. C11H16NO3 requires: [M+H]+, 210.1130. 
 
(1R*,2S*,5S*)-Ethyl 2-hydroxy-2-(hydroxymethyl)-3-oxo-8-azabicyclo[3.2.1]octane-8-
carboxylate (±9). To a stirred suspension of K2OsO4·2H2O (5.2 mg, 0.01 mmol), 
quinuclidine (7.8 mg, 0.07 mmol) and N-methylmorpholine-N-oxide (336 mg, 2.87 mmol) in 
H2O (0.64 ml) a solution of enone (±)-8 (300 mg, 1.40 mmol) in acetone (3.36 ml) was 
added. The reaction mixture was stirred vigorously at room temperature for 3 days, then solid 
sodium metabisulfite (~1.5 g) was added and vigorous stirring was continued for a further 
hour. The reaction mixture was diluted with DCM (10 ml). The solid was removed by 
filtration through a pad of Celite™ and washed with DCM (20 ml). The combined filtrate and 
washings were dried and evaporated to dryness and the residue purified by flash 
chromatography on silica gel eluting with 3% MeOH in DCM to give (±)-9 as a pale yellow 
 17
oil (300 mg, 86%); νmax/cm-1 (CHCl3): 3526, 3410, 2978, 1726, 1676, 1115, 1068; 1H NMR 
δH (ppm) (CDCl3, 500 MHz): 4.61 (1 H, br s, NCHCH2CO), 4.50 (1 H, br s, NCHC), 4.22 (2 
H, m, OCH2CH3), 4.06 (1 H, dd, J = 18.5 and 5.5 Hz, CCH2OH), 3.56-3.54 (1 H, m, 
CCH2OH), 3.15 (1 H, d, J = 20.6 Hz, CHCH2axCO), 2.41 (1 H, br s, COH), 2.22 (1 H, d, J = 
20.6 Hz, CHCH2eqCO), 2.05-2.00 (2 H, m, CHCH2exoCH2exoCH), 1.64 (1 H, br s, CH2OH), 
1.61-1.57 (2 H, m, CHCH2endoCH2endoCH), 1.31 (3 H, m, OCH2CH3); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 208.4 (C, C=Oketone), 155.7 (C, C=Ocarbamate), 80.0 (C, CCH2OH), 62.9 
(CH2, CCH2OH), 62.2 (CH2, OCH2CH3), 59.4 (CH, NCHC), 54.1 (CH, NCHCH2CO), 46.4 
(CH2, CHCH2CO), 28.3 (CH2, CHCH2CH2CHCH2), 23.9 (CH2, CHCH2CH2CHCH2), 15.0 
(CH3, OCH2CH3); m/z (ES+) 244 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 244.1189. 
C11H18NO5 requires: [M+H]+, 244.1185. 
 
(1R*,2S*,5S*)-Ethyl 2',3-dioxo-8-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,4'-
[1,3]dioxolane]-8-carboxylate (±)-4, and resolution to give 4 and ent-4. To a stirred solution 
of diol (±)-9 (150 mg, 6.15 mmol) and pyridine (0.5 ml, 6.15 mmol) in DCM (3 ml) a 
solution of triphosgene (0.182 mg, 6.15 mmol) in DCM (0.4 ml) was added at 0 oC under a 
nitrogen atmosphere. The mixture was stirred between 0 oC and room temperature for 8 
hours. It was then quenched with H2O (2 ml). The organic phase was diluted with DCM (20 
ml), separated, dried over MgSO4 and concentrated. The residue was purified by flash 
chromatography on silica gel eluting with 50% EtOAc in n-hexane to give (±)-4 as a 
colourless solid (100 mg, 60%); m.p.: 113.4-114.3 oC; νmax/cm-1 (CHCl3): 1806, 1692, 1426, 
1335, 1047; 1H NMR δH (ppm) (CDCl3, 500 MHz): 5.04-4.99 (1 H, m, CCH2O), 4.85-4.64 (2 
H, m, NCHC and NCHCH2CO), 4.27-4.18 (2 H, m, OCH2CH3), 4.00 (1 H, d, J = 8.8 Hz, 
CCH2O), 3.15-3.01 (1 H, br m, CHCH2axCO), 2.52 (1 H, dd, J = 15.2 and 2.2 Hz, 
CHCH2eqCO), 2.16-2.08 (2 H, m, CHCH2exoCH2exoCH), 1.63-1.61 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.33-1.24 (4 H, m, OCH2CH3 and CHCH2endoCH2endoCHCH2); 
13C NMR δc (ppm) (CDCl3, 91 MHz): 199.6 (C, C=Oketone), 154.4 (C, C=Ocarbamate), 152.6 (C, 
C=Ocarbonate), 85.2 (C, CCH2O), 65.8 (CH2, CCH2O), 62.4 (CH2, OCH2CH3), 59.4 (CH, 
NCHC), 54.0 (CH, NCHCH2CO), 47.1 (CH2, CHCH2CO), 27.9 (CH2, CHCH2CH2CHCH2), 
23.8 (CH2, CHCH2CH2CHCH2), 14.9 (CH3, OCH2CH3); m/z (ES+) 270 ([M+H]+, 100%); 
m/z (ES+) found: [M+H]+, 270.0976. C12H16NO6 requires: [M+H]+, 270.0978. 
The racemic compound was separated into single enantiomers by SFC (Chiralpak AD-H 
column, 220 nm, 90/10 CO2/iso-propanol, 10 ml/min, 35 oC, Outlet P=100 bar): 
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ent-4: enantiomer 1, Rt = 5.20 min, colourless solid., m.p.: 126.5-128.1 oC; [α]D20 -25.2 (c 1, 
CHCl3); 99% ee.  
4: enantiomer 2, Rt = 6.35 min, colourless solid, m.p.: 116.1-120.2 oC; [α]D20 +21.0 (c 0.3, 
CHCl3); 97% ee. 
 
(1R*,2S*,3S*,5S*)-Ethyl 3-hydroxy-8H-spiro[8-azabicyclo[3.2.1]octane-2,2’-oxirane]-8-
carboxylate (±)-10. CeCl3·7H2O (7.8 g, 0.02 mol) was added to a solution of enone (±)-8 
(4.0 g, 0.02 mol) in MeOH (30 ml). The mixture was cooled to 0 oC and then NaBH4 (0.79 g, 
0.02 mol) was added portionwise. After stirring at 0 oC for 1 hour, the mixture was quenched 
with water (3 ml). The organic solvent was evaporated in vacuo and the residue diluted with 
EtOAc (30 ml), washed with 0.1 M HCl (10 ml), brine (10 ml), dried over MgSO4 and 
concentrated. It was then purified by flash chromatography on silica gel eluting with 50% 
EtOAc in n-hexane and then with 5% MeOH in DCM to yield the allylic alcohol as a 
colourless oil (3.8 g, 95%); νmax/cm-1 (CHCl3): 3518, 1697, 908; 1H NMR δH (ppm) (DMSO-
d6, 500 MHz): 4.92 (1 H, d, J = 6.5 Hz, OH), 4.90-4.89 (1 H, m, C=CH2), 4.80 (1 H, br s, 
C=CH2), 4.46 (1 H, d, J = 6.3 Hz, NCHC), 4.32-4.29 (1 H, m, CHCH2CHOH), 4.16 (1 H, br 
s, NCHCH2CHOH), 4.01 (2 H, q, J = 7.0 Hz, OCH2CH3), 1.91-1.87 (3 H, m, CHCH2CHOH 
and CHCH2exoCH2exoCH), 1.76-1.67 (1 H, m, CHCH2endoCH2endoCHCH2), 1.66-1.57 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.55-1.40 (1 H, m, CHCH2CHOH), 1.16 (3 H, t, J = 7.1 Hz, 
OCH2CH3); 1H NMR δH (ppm) (CDCl3, 500 MHz): 5.08-4.79 (2 H, br m, C=CH2), 4.75-4.51 
(1 H, br m, NCHC), 4.50-4.40 (1 H, br s, CHCH2CHOH), 4.39-4.28 (1 H, br s, 
NCHCH2CHOH), 4.15-4.02 (2 H, m, OCH2CH3), 2.65-1.97 (4 H, br m, OH, CHCH2CHOH 
and CHCH2exoCH2exoCH), 1.76-1.52 (3 H, br m, CHCH2endoCH2endoCH and CHCH2CHOH), 
1.25-1.20 (3 H, m, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 154.5 (C, C=Ocarbamate), 
150.4 (C, C=CH2), 106.3 (CH2, C=CH2), 66.5 (CH, CHCH2CHOH), 61.4 (CH2, OCH2CH3), 
60.3 (CH, NCHC), 53.9 (CH, NCHCH2CHOH), 43.1 (CH2, CHCH2CHOH), 29.4 (CH2, 
CHCH2CH2CHCH2), 28.1 (CH2, CHCH2CH2CHCH2), 15.1 (CH3, OCH2CH3); m/z (ES+) 166 
([M+H (-OH and -C2H5)]+ 100%); m/z (ES+) found: [M+H]+, 212.1287. C11H18NO3 
requires: [M+H]+, 212.1287. 
The allylic alcohol (4.9 g, 0.02 mol) was dissolved in DCM (60 ml) and cooled to 0 oC. Then 
m-CPBA 75% w (6.2 g, 0.03 mol) was added portionwise and the mixture stirred at 0 oC for 3 
h. A white solid formed during the reaction. The suspension was diluted with DCM (20 ml); 
it was washed with a 10% solution of sodium tiosulfate (40 ml), then with 1.0 M NaOH (40 
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ml) and finally with brine (40 ml). The organic layer was dried over MgSO4 and then 
concentrated under vacuum. The residue was purified by flash chromatography on silica gel 
eluting with 50% EtOAc in n-hexane and then with 5% MeOH in DCM to yield (±)-10 as a 
colourless oil (3.7 g, 70%); νmax/cm-1 (CHCl3): 3525, 1707, 1487, 1123; 1H NMR δH (ppm) 
(DMSO-d6, 500 MHz): 4.33 (1 H, d, J = 9.0 Hz, OH), 4.26 (1 H, br s, NCHCH2CHOH), 
4.08-4.00 (3 H, m, OCH2CH3 and CHCH2CHOH), 3.78 (1 H, br s, NCHC), 2.82 (1 H, d, J = 
5.3 Hz, CCH2O), 2.66 (1 H, d, J = 5.3 Hz, CCH2O), 1.92-1.86 (3 H, m, CHCH2CHOH and 
CHCH2exoCH2exoCH), 1.76-1.69 (2 H, m, CHCH2endoCH2endoCH), 1.59 (1 H, m, 
CHCH2CHOH), 1.17 (3 H, br t, OCH2CH3); 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.44 (1 
H, br s, NCHCH2CHOH), 4.17-4.10 (3 H, m, OCH2CH3 and CHCH2CHOH), 4.09-3.90 (1 H, 
m, NCHC), 3.04 (1 H, d, J = 5.3 Hz, CCH2O), 2.76 (1 H, br s, CCH2O), 2.16-2.12 (1 H, m, J 
= 13.0, 6.1 and 2.9 Hz, CHCH2eqCHOH), 2.08-1.96 (2 H, m, CHCH2exoCH2exoCH), 1.84-1.76 
(2 H, m, CHCH2endoCH2endoCH and CHCH2CHOH), 1.74-1.70 (2 H, m, CHCH2axCHOH and 
CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 
MHz): 154.3 (C, C=Ocarbamate), 61.9 (CH, CHCH2CHOH), 61.6 (CH2, OCH2CH3), 61.2 (C, 
CCH2O), 58.8 (CH, NCHC), 52.7 (CH, NCHCH2CHOH), 48.8 (CH2, CCH2O), 40.2 (CH2, 
CHCH2CHOH), 26.6 (CH2, CHCH2CH2CH), 26.4 (CH2, CHCH2CH2CH), 14.7 (CH3, 
OCH2CH3); m/z (ES+) 250 ([M+Na]+, 100%); m/z (ES+) found: [M+H]+, 228.1247. 
C11H18NO4 requires: [M+H]+, 228.1236. 
 
(1R*,2R*,5S*)-Ethyl 3'-methyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate (±)-5a, and resolution to give 5a and ent-5a. Epoxide (±)-
10 (500 mg, 2.2 mmol) was dissolved in EtOH (5 ml) and then methylamine 33% wt in EtOH 
(0.27 ml, 2.2 mmol) was added. The solution was heated to 70 oC overnight in a sealed tube. 
The reaction mixture was cooled to RT and concentrated under reduced pressure. The residue 
was purified by SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to 
yield (±)-11a as a colourless oil. It was dissolved in DMSO (20 ml) and TFA (180 µl, 2.39 
mmol) was added followed by IBX (1.82 g, 6.5 mmol). The reaction mixture was stirred at 
RT overnight. Then 3 ml of water were added and after 20 minutes stirring a white solid was 
filtered. The filtrate was diluted with EtOAc (15 ml) and purified by SCX cartridge eluting 
first with MeOH and then with 2.0 M NH3 in MeOH. The ammonia fractions were further 
purified by flash chromatography on silica gel eluting with 5% MeOH in DCM to yield the 
ketone a as a colourless oil (0.4 g, 72% slightly impure). 
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A small portion was further purified by chromatography on silica gel eluting with 5% MeOH 
in DCM to get full characterization data while all the rest of the material was taken through 
the next step:  νmax/cm-1 (CHCl3): 2981, 1697, 1430, 1332, 1108, 1034, 765; 1H NMR δH 
(ppm) (CDCl3, 500 MHz): 4.57 (1 H, br s, NCHCH2CO), 4.48-4.26 (1 H, br s, NCHC), 4.25-
4.18 (2 H, m, OCH2CH3), 3.24 (1 H, d, J = 12.2 Hz, CCH2NH), 3.18 (1 H, br d, J = 14.6, 
CHCH2axCO), 3.00 (2 H, br s, OH and NH), 2.49 (3 H, s, NHCH3), 2.30-2.24 (1 H, br s, 
CCH2NH), 2.17 (1 H, dd, J = 14.6 Hz and 1.9, CHCH2eqCO), 1.99-1.96 (2 H, m, 
CHCH2exoCH2exoCH), 1.55-1.49 (2 H, m, CHCH2endoCH2endoCH), 1.30 (3 H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 209.3 (C, C=Oketone), 155.2 (C, 
C=Ocarbamate), 78.3 (C, CCH2NH), 61.8 (CH2, OCH2CH3), 61.4 (CH, NCHC), 53.7 (CH, 
NCHCH2CO), 52.8 (CH2, CCH2NH), 46.2 (CH2, CHCH2CO), 37.3 (CH3, NHCH3), 28.2 
(CH2, CHCH2CH2CH), 23.5 (CH2, CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z (ES+) 257 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 257.1494. C12H21N2O4 requires: [M+H]+, 
257.1501. 
The ketone (0.4 g, 1.56 mmol) was dissolved in DCM (20 ml); pyridine (1.6 ml, 0.02 mol) 
was added and the mixture cooled to 0 oC. Triphosgene (0.51 g, 1.72 mmol) was 
subsequently added portionwise and the final mixture was stirred at RT for 6 h. It was then 
diluted with DCM (20 ml), washed with 0.1 M HCl (20 ml), H2O (20 ml), brine (20 ml), 
dried over MgSO4 and concentrated. The residue was purified by flash chromatography on 
silica gel eluting with EtOAc to yield (±)-5a as a pale yellow oil that solidified at room 
temperature (210 mg, 48%); m.p.: 110.3-113.2 ºC; νmax /cm-1 (CHCl3): 2981, 1784, 1716, 
1695, 1441, 1337, 1122, 1037, 934, 755; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.76-4.48 (2 
H, m, NCHCH2CO and NCHC), 4.33-4.14 (3 H, m, OCH2CH3 and CCH2N), 3.17-3.02 (2 H, 
m, CHCH2axCO and CCH2N), 2.91 (3 H, s, NCH3), 2.45 (1 H, dd, J = 14.8 and 1.6 Hz, 
CHCH2eqCO), 2.18-2.00 (2 H, m, CHCH2exoCH2exoCH), 1.63-1.55 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.36-1.25 (4 H, m, CHCH2endoCH2endoCHCH2 and OCH2CH3); 1H 
NMR δH (ppm) (CDCl3, 360 MHz, 56 oC): 4.75-4.55 (2 H, m, NCHCH2CO and NCHC), 
4.34-4.20 (2 H, m, OCH2CH3), 4.17 (1 H, d, J = 8.9 Hz, CCH2N), 3.16 (1 H, br d, J = 14.8 
Hz, CHCH2axCO), 3.04 (1 H, d, J = 8.9 Hz, CCH2N), 2.92 (3 H, s, NCH3), 2.46 (1 H, dd, J = 
14.8 and 1.9 Hz, CHCH2eqCO), 2.19-2.03 (2 H, m, CHCH2exoCH2exoCH), 1.68-1.60 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.36-1.27 (4 H, m, CHCH2endoCH2endoCHCH2 and OCH2CH3); 
13C NMR δc (ppm) (CDCl3, 91 MHz): 201.0 (C, C=Oketone), 155.8 (C, C=Ocyclic carbamate), 
154.6 (C, C=Ocarbamate), 82.3 (C, CCH2N), 62.3 (CH2, OCH2CH3), 60.2 (CH, NCHC), 54.0 
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(CH, NCHCH2CO), 47.9 (CH2, CCH2N), 46.8 (CH2, CHCH2CO), 31.5 (CH3, NCH3), 27.9 
(CH2, CHCH2CH2CHCH2), 23.8 (CH2, CHCH2CH2CHCH2), 15.0 (CH3, OCH2CH3); m/z 
(ES+) 283 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 283.1292. C13H19N2O5 requires: 
[M+H]+, 283.1294. 
The racemic compound was then separated into single enantiomers by SFC (Chiralpak AD-H 
column, 220 nm, 85/15 CO2/MeOH, 10 ml/min, 35 oC, Outlet P=100 bar): 
5a: enantiomer 1, Rt = 3.74 min; 70 mg, colourless solid, m.p. 119.1-120.0 ºC; [α]D20 -49.3 (c 
1, CHCl3); >99% enantiomeric excess,  
ent-5a: enantiomer 2, Rt = 4.31 min; 70 mg, colourless solid, m.p. 119.1-120.0 ºC; [α]D20 
+49.2 (c 1, CHCl3); >99% enantiomeric excess. 
 
(1R*,2R*,5S*)-Ethyl 3'-iso-propyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate (±)-5b and resolution to give 5b and ent-5b. Epoxide (±)-10 
(0.4 g, 1.76 mmol) was dissolved in EtOH (7 ml) and then iso-propylamine (0.12 ml, 1.41 
mmol) was added. The solution was heated to reflux temperature overnight. The reaction 
mixture was cooled to RT and concentrated under reduced pressure. The residue was purified 
by SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield the 
amino alcohol (±)-11b as a colourless oil. It was then dissolved in DMSO (10 ml) and TFA 
(0.1 ml, 1.35 mmol) was added followed by IBX (1.03 g, 3.70 mmol). The reaction mixture 
was stirred at RT overnight. Then 3 ml of water were added and after 10 minutes stirring a 
white solid was filtered. The solid was washed with further EtOAc and then volatiles were 
concentrated under reduced pressure. The residue was purified by SCX cartridge eluting first 
with MeOH and then with 2.0 M NH3 in MeOH. The ammonia fractions were concentrated, 
diluted with EtOAc (20 ml), washed with water (20 ml), dried over Na2SO4 and concentrated. 
They were further purified by flash chromatography on silica gel eluting with 5% MeOH in 
DCM to yield the ketone as a colourless oil (210 mg, 60%); νmax/cm-1 (CHCl3): 3316, 2966, 
1697, 1424, 1382, 1314, 1106, 1022, 765; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.56 (1 H, 
br s, NCHCH2CO), 4.42-4.18 (3 H, m, NCHC and OCH2CH3), 3.24-3.17 (2 H, m, CCH2NH 
and CHCH2axCO), 2.82-2.74 (1 H, m, J = 6.3 Hz, NHCH(CH3)2), 2.21-2.14 (2 H, m, 
CCH2NH and CHCH2eqCO), 1.97-1.91 (2 H, m, CHCH2exoCH2exoCH), 1.54-1.46 (2 H, m, 
CHCH2endoCH2endoCH), 1.28 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.09 (3 H, d, J = 6.3 Hz, 
NHCH(CH3)2), 1.05 (3 H, d, J = 6.3 Hz, NHCH(CH3)2); 1H NMR δH (ppm) (CDCl3, 360 
MHz, 56 oC): 4.55 (1 H, br s, NCHCH2CO), 4.33 (1 H, br s, NCHC), 4.27-3.80 (4 H, m, 
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OCH2CH3, NH and OH), 3.27-3.17 (2 H, m, CCH2NH and CHCH2axCO), 2.82-2.74 (1 H, m, 
J = 6.3 Hz, NHCH(CH3)2), 2.34 (1 H, d, J = 12.3 Hz, CCH2NH), 2.15 (1 H, dd, J = 11.6 and 
1.8 Hz, CHCH2eqCO), 2.06-1.87 (2 H, m, CHCH2exoCH2exoCH), 1.58-1.44 (2 H, m, 
CHCH2endoCH2endoCH), 1.28 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.54-1.08 (6 H, m, 
NHCH(CH3)2); 13C NMR δc (ppm) (CDCl3, 91 MHz): 209.4 (C, C=Oketone), 154.7 (C, 
C=Ocarbamate), 77.8 (C, CCH2NH), 61.4 (CH2, OCH2CH3), 61.1 (CH, NCHC), 53.4 (CH, 
NCHCH2CO), 49.9 (CH, NHCH(CH3)2), 47.2 (CH2, CCH2NH), 45.9 (CH2, CHCH2CO), 27.8 
(CH2, CHCH2CH2CH), 23.3 (CH2, CHCH2CH2CH), 22.2 (CH3, NHCH(CH3)2), 22.0 (CH3, 
NHCH(CH3)2), 14.7 (CH3, OCH2CH3); m/z (ES+) 285 ([M+H]+, 100%); m/z (ES+) found: 
[M+H]+, 285.1822. C14H25N2O4 requires: [M+H]+, 285.1814. 
The above ketone (0.21 g, 0.74 mmol) was dissolved in DCM (10 ml); pyridine (0.75 ml, 7.4 
mmol) was added and the mixture cooled to 0 oC. Triphosgene (241 mg, 0.81 mmol) was 
slowly added portionwise and the final mixture was stirred at RT for 7 h. It was then diluted 
with DCM (10 ml), washed with 0.1 M HCl (10 ml), H2O (20 ml), brine (20 ml), dried over 
MgSO4 and concentrated. The residue was purified by flash chromatography on silica gel 
eluting with 3% MeOH in DCM and, after evaporation of the volatiles, was triturated with 
Et2O to yield (±)-5b as a colourless solid (180 mg, 78%); m.p.: 148.5-150.0 oC; νmax /cm-1 
(CHCl3): 2974, 2364, 1750, 1695, 1412, 1332, 1275, 1101, 1034, 930, 755; 1H NMR δH 
(ppm) (DMSO-d6, 360 MHz): 4.70-4.41 (2 H, br m, NCHCH2CO and NCHC), 4.19-4.01 (2 
H, m, OCH2CH3), 3.96-3.81 (2 H, m, CCH2N and NCH(CH3)2), 3.23 (1 H, d, J = 9.3 Hz, 
CCH2N), 2.90 (1 H, dd, J = 15.3 Hz and 4.0, CHCH2axCO), 2.44 (1 H, dd, J = 15.3 Hz and 
1.8, CHCH2eqCO), 2.15-1.95 (2 H, m, CHCH2exoCH2exoCH), 1.57-1.45 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.40-1.28 (1 H, m, CHCH2endoCH2endoCHCH2), 1.22 (3 H, t, J = 
7.3 Hz, OCH2CH3), 1.16 (3 H, d, J = 6.7 Hz, NCH(CH3)2), 1.13 (3 H, d, J = 6.7 Hz, 
NCH(CH3)2); 13C NMR δc (ppm) (DMSO-d6, 91 MHz): 201.9 (C, C=Oketone), 154.1 (C, 
C=Ocarbamate and C=Ocyclic carbamate), 82.1 (C, CCH2N), 61.2 (CH2, OCH2CH3), 59.5 (CH, 
NCHC), 53.6 (CH, NCHCH2CO), 45.8 (CH2, CHCH2CO), 45.0 (CH, NCH(CH3)2), 40.8 
(CH2, CCH2N), 27.6 (CH2, CHCH2CH2CHCH2), 23.2 (CH2, CHCH2CH2CHCH2), 19.8 (CH3, 
NCH(CH3)2), 19.7 (CH3, NCH(CH3)2), 14.8 (CH3, OCH2CH3); m/z (ES+) 311 ([M+H]+, 
100%); m/z (ES+) found: [M+H]+, 311.1600. C15H23N2O5 requires: [M+H]+, 311.1607. 
The racemic compound was then separated into single enantiomers by SFC (Chiralpak AD-H 
column, 220 nm, 80/20 CO2/MeOH, 10 ml/min, 35 oC, Outlet P=100 bar): 
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5b: enantiomer 1, Rt = 2.38 min; 50 mg, colourless solid, m.p. 147.4-148.1 oC; [α]D20 +125.5 
(c 1, CHCl3); >99% enantiomeric excess. 
ent-5b: enantiomer 2, Rt = 3.16 min; 50 mg, colourless solid, m.p. 147.4-148.1 oC; [α]D20 -
125.6 (c 1, CHCl3); >99% enantiomeric excess. 
 
(1S*,2S*,5R*)-Ethyl 3'-tert-butyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate (±)-5c and resolution to give ent-5c. Epoxide (±)-10 (0.6 g, 
2.64 mmol) was dissolved in EtOH (5 ml) and then tbutylamine (0.28 ml, 2.64 mmol) was 
added. The solution was heated to 70 oC overnight in a sealed tube. The reaction mixture was 
cooled to RT and concentrated under reduced pressure. The residue was purified by SCX 
cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield (±)-11c as a 
colourless oil (0.79 g, quantitative yield); νmax/cm-1 (CHCl3): 3374, 2964, 1688, 1434, 1314, 
1109, 764; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.38-4.26 (1 H, br s, NCHCH2CHOH), 
4.24-3.98 (3 H, m, NCHC and OCH2CH3), 3.88-3.75 (1 H, m, CHCH2CHaxOH), 2.78-2.68 (2 
H, m, CCH2NH), 1.99-1.84 (2 H, m, CHCH2exoCH2exoCH), 1.83-1.65 (2 H, m, 
CHCH2CHOH), 1.65-1.49 (2 H, m, CHCH2endoCH2endoCH), 1.31-1.16 (3 H, m, OCH2CH3), 
1.13-0.95 (9 H, m, NHC(CH3)3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 155.6 (C, 
C=Ocarbamate), 73.8 (C, CCH2NH), 69.5 (CH, CHCH2CHOH), 61.5 (CH2, OCH2CH3), 59.9 
(CH, NCHC), 52.4 (CH, NCHCH2CHOH), 50.8 (C, NHC(CH3)3), 49.1 (CH2, CCH2NH), 
36.4 (CH2, CHCH2CHOH), 29.3 (CH3, NHC(CH3)3), 27.8 (CH2, CHCH2CH2CH), 25.1 (CH2, 
CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z (ES+) 301 ([M+H]+, 100%); m/z (ES+) found: 
[M+H]+, 301.2125. C15H29N2O4 requires: [M+H]+, 301.2127. 
Intermediate (±)-11c (0.69 g, 2.3 mmol) was dissolved in DMSO (30 ml) and TFA (0.2 ml, 
2.53 mmol) was added followed by IBX (1.9 g, 6.9 mmol). The reaction mixture was stirred 
at RT overnight. Then 5 ml of water were added and after 10 minutes stirring a white solid 
was filtered. The solid was washed with further EtOAc and then volatiles were concentrated 
under reduced pressure. The residue was purified by SCX cartridge eluting first with MeOH 
and then with 2.0 M NH3 in MeOH to yield the ketone as a yellow oil (0.6 g, 88%); νmax/cm-1 
(CHCl3): 3327, 2964, 1694, 1425, 1313, 1108, 1022, 748; 1H NMR δH (ppm) (CDCl3, 500 
MHz): 4.56 (1 H, br s, NCHCH2CO), 4.37 (1 H, br s, NCHC), 4.24-4.20 (2 H, m, OCH2CH3), 
3.27-3.02 (2 H, m, CHCH2axCO and CCH2NH), 2.30-2.19 (1 H, br d, CCH2NH), 2.16 (1 H, 
dd, J = 20.0 and 3.6 Hz, CHCH2eqCO), 1.98-1.96 (2 H, m, CHCH2exoCH2exoCH), 1.51-1.49 (2 
H, m, CHCH2endoCH2endoCH), 1.29 (3 H, m, J = 7.1 Hz, OCH2CH3), 1.1 (9 H, s, NHC(CH3)3), 
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13C NMR δc (ppm) (CDCl3, 91 MHz): 210.0 (C, C=Oketone), 155.1 (C, C=Ocarbamate), 77.4 (C, 
CCH2NH from HMBC), 61.7 (CH2, OCH2CH3 and CH, NCHC), 53.7 (CH, NCHCH2CO), 
51.1 (C, NHC(CH3)3), 46.3 (CH2, CHCH2CO), 43.7 (CH2, CCH2NH), 29.4 (CH3, 
NHC(CH3)3), 28.3 (CH2, CHCH2CH2CHCH2), 23.0 (CH2, CHCH2CH2CHCH2), 15.1 (CH3, 
OCH2CH3); m/z (ES+) 299 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 299.1966. 
C15H27N2O4 requires: [M+H]+, 299.1971. 
The ketone (0.6 g, 2.02 mmol) was dissolved in DCM (20 ml); pyridine (2 ml, 0.02 mol) was 
added and the mixture cooled to 0 oC. Triphosgene (660 mg, 2.2 mmol) was susbequently 
added portionwise and the final mixture was stirred at RT for 2 h. It was then diluted with 
DCM (10 ml), washed with 0.1 M HCl, H2O (20 ml), brine (20 ml), dried over MgSO4 and 
concentrated. The residue was purified by flash chromatography on silica gel eluting with 
50% EtOAc in n-hexane to yield (±)-5c as a colourless oil (250 mg, 38%); νmax/cm-1 (CHCl3): 
2978, 1760, 1704, 1408, 750; 1H NMR δH (ppm) (CDCl3, 360 MHz, 56 oC): 4.70-4.52 (2 H, 
br m, NCHCH2CO and NCHC), 4.26-4.17 (3 H, m, OCH2CH3 and CCH2N), 3.12 (1 H, br dd, 
J = 14.7 and 1.9 Hz, CHCH2axCO), 3.05 (1 H, d, J = 9.1 Hz, CCH2N), 2.41 (1 H, dd, J = 14.7 
and 1.9 Hz, CHCH2eqCO), 2.10-2.00 (2 H, m, CHCH2exoCH2exoCH), 1.68-1.52 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.40 (9 H, s, NC(CH3)3), 1.35-1.26 (4 H, m, 
CHCH2endoCH2endoCHCH2 and OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 201.4 (C, 
C=Oketone), 154.8 (C, C=Ocarbamate), 154.0 (C, C=Ocarbamate), 81.3 (C, CCH2N), 62.1 (CH2, 
OCH2CH3), 60.1 (CH, NCHC), 54.3 (C, NC(CH3)3), 54.0 (CH, NCHCH2CO), 46.7 (CH2, 
CCH2N), 44.4 (CH2, CHCH2CO), 28.0 (CH2, CHCH2CH2CHCH2), 27.8 (CH3, NC(CH3)3), 
23.8 (CH2, CHCH2CH2CHCH2), 14.9 (CH3, OCH2CH3); m/z (ES+) 325 ([M+H]+, 100%); 
m/z (ES+) found: [M+H]+, 325.1764. C16H25N2O5 requires: [M+H]+, 325.1763. 
The racemic compound was then separated into single enantiomers by SFC (Chiralpak IA 
column, 220 nm, 87/13 CO2/iso-propanol, 10 ml/min, 35 oC, Outlet P=100 bar). 
ent-5c: enantiomer 1, Rt = 3.45 min; colourless oil, [α]D20 -35.3 (c 1, CHCl3); >99% ee.  
 
(1R*,2R*,5S*)-ethyl 3’-benzyl-2’,3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5’-
[1,3]oxazolidine]-8-carboxylate (±)-5d and resolution to give 5d and ent-5d. 
Epoxide (±)-10 (0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and benzylamine (0.24 ml, 
2.2 mmol) was added. The solution was heated to reflux temperature overnight. The reaction 
mixture was cooled to RT and concentrated under reduced pressure. The residue was purified 
by SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield (±)-
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11d as a colourless oil (0.73 g, quantitative yield); νmax/cm-1 (CHCl3): 3405, 1690, 1113; 1H 
NMR δH (ppm) (CDCl3, 500 MHz): 7.34-7.25 (5 H, m, CHAr), 4.31 (1 H, br s, 
NCHCH2CHOH), 4.19-4.09 (3 H, m, OCH2CH3 and NCHC), 3.85-3.77 (3 H, m, NCH2Ar 
and CHCH2CHOH), 3.19 (3 H, br s, OH, OH, NH), 2.82 (1 H, d, J = 12.1 Hz, CCH2NH), 
2.78 (1 H, d, J = 12.1 Hz, CCH2NH), 1.92-1.69 (4 H, m, CHCH2exoCH2exoCH and 
CHCH2CHOH), 1.57-1.49 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 155.6 (C, C=Ocarbamate), 139.6 (C, CAr), 
129.0 (CH, CHAr), 128.5 (CH, CHAr), 127.8 (CH, CHAr), 74.6 (C, CCH2NH), 69.4 (CH, 
CHCH2CHOH), 61.6 (CH2, OCH2CH3), 59.9 (CH, NCHC), 55.5 (CH2, CCH2NH), 54.6 
(CH2, NHCH2Ar), 52.5 (CH, NCHCH2CHOH), 36.5 (CH2, CHCH2CHOH), 27.7 (CH2, 
CHCH2CH2CH), 25.0 (CH2, CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z (ES+) 335 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 335.1974. C18H27N2O4 requires: [M+H]+, 335. 
1971. 
Amino alcohol (±)-11d (0.73 g, 2.2 mmol) was dissolved in DMSO (20 ml) and TFA (0.18 
ml, 2.3 mmol) was added followed by IBX (1.85 g, 6.6 mmol). The reaction mixture was 
stirred at RT overnight. Then 3 ml of water were added and after 10 minutes of stirring a 
white solid was filtered. The filtrate was diluted with EtOAc (30 ml), washed with water, 
dried over Na2SO4 and concentrated. It was then purified by SCX cartridge eluting first with 
MeOH and then with 2.0 M NH3 in MeOH. The amonia fractions were further purified by 
flash chromatography on silica gel eluting with 3% MeOH in DCM to yield the ketone as a 
yellow oil (0.44 g, 63%); νmax/cm-1 (CHCl3): 3404, 2978, 1681, 1422, 1314, 1105, 747; 1H 
NMR δH (ppm) (CDCl3, 500 MHz): 7.34-7.25 (5 H, m, CHAr), 4.56 (1 H, br s, NCHCH2CO), 
4.45-4.18 (3 H, m, OCH2CH3 and NCHC), 3.84 (1 H, d, J = 13.4 Hz, NCH2Ar), 3.80 (1 H, d, 
J = 13.4 Hz, NCH2Ar), 3.25 (1 H, d, J = 12.2 Hz, CCH2N), 3.17 (1 H, br d, CHCH2axCO), 
2.28 (1 H, d, J = 12.2 Hz, CCH2NH), 2.16 (1 H, dd, J = 14.6 and 1.7 Hz, CHCH2eqCO), 1.97-
1.89 (2 H, m, CHCH2exoCH2exoCH), 1.52-1.42 (2 H, m, CHCH2endoCH2endoCH), 1.30 (3 H, t, J 
= 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 209.5 (C, C=Oketone), 155.2 (C, 
C=Ocarbamate), 140.0 (C, CAr), 128.9 (CH, CHAr), 128.4 (CH, CHAr), 127.6 (CH, CHAr), 77.7 
(C, CCH2NH), 61.8 (CH2, OCH2CH3), 61.4 (CH, NCHC), 54.6 (CH2, NCH2Ar), 53.7 (CH, 
NCHCH2CO), 50.3 (CH2, CCH2NH), 46.2 (CH2, CHCH2CO), 28.3 (CH2, 
CHCH2CH2CHCH2), 23.4 (CH2, CHCH2CH2CHCH2), 15.1 (CH3, OCH2CH3); m/z (ES+) 333 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 333.1820. C18H25N2O4 requires: [M+H]+, 
333.1814. 
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The ketone (0.44 g, 1.35 mmol) was dissolved in DCM (20 ml); pyridine (1.3 ml, 0.01 mol) 
was added and the mixture cooled to 0 oC. Triphosgene (432 mg, 1.46 mmol) was 
subsequently added portionwise and the final mixture was stirred at RT for 7 h. It was then 
diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), H2O (20 ml), brine (20 ml), 
dried over MgSO4 and concentrated. The residue was purified by flash chromatography on 
silica gel eluting with 50% EtOAc in n-hexane to yield 330 mg (70%) of (±)-11d as a pale 
yellow solid; m.p.: 123.0-123.9 oC; νmax /cm-1 (CHCl3): 2968, 1760, 1698, 1418, 1332, 1106; 
1H NMR δH (ppm) (CDCl3, 500 MHz): 7.40-7.26 (5 H, m, CHAr), 4.65 (1 H, br s, 
NCHCH2CO), 4.51-4.47 (2 H, m, NCH2Ar and NCHC), 4.39 (1 H, d, J = 15.0 Hz, NCH2Ar), 
4.30-4.21 (2 H, m, OCH2CH3), 4.03 (1 H, d, J = 8.8 Hz, CCH2N), 3.21-3.07 (1 H, br d, J = 
14.8 Hz, CHCH2axCO), 2.86 (1 H, br d, J = 8.8 Hz, CCH2N), 2.43 (1 H, d, J = 14.8 Hz, 
CHCH2eqCO), 2.08-1.98 (2 H, m, CHCH2exoCH2exoCH), 1.53 (1 H, m, 
CH2CHCH2endoCH2endoCH), 1.37-1.27 (3 H, m, OCH2CH3), 1.26-1.20 (1 H, m, 
CH2CHCH2endoCH2endoCH); 13C NMR δc (ppm) (91 MHz, CDCl3): 200.8 (C, C=Oketone), 
155.7 (C, C=O), 154.7 (C, C=O), 135.8 (C, CAr), 129.4 (CH, CHAr), 128.6 (CH, CHAr), 128.4 
(CH, CHAr), 82.7 (C, CCH2N), 62.3 (CH2, OCH2CH3), 60.2 (CH, NCHC), 54.0 (CH, 
NCHCH2CO), 48.8 (CH2, NCH2Ar), 46.8 (CH2, CHCH2CO), 45.3 (CH2, NCH2C), 27.9 
(CH2, CH2CHCH2CH2CH), 23.9 (CH2, CH2CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z 
(ES+) 359 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 359.1619. C19H23N2O5 requires: 
[M+H]+, 359.1607. 
The racemic compound was then separated into single enantiomers by SFC (Chiralpak AS-H 
column, 220 nm, 85/15 CO2/MeOH, 10 ml/min, 40 oC, Outlet P=100 bar): 
ent-11d: enantiomer 1; Rt = 3.60 min; colourless solid, 80 mg, m.p. 82.5-88.3 oC; [α]D20 -5.0 
(c 1, CHCl3); >99% ee. 
11d enantiomer 2, Rt = 4.19 min, colourless solid, 80 mg, m.p. 88.5-90.7 oC [α]D20 +4.6 (c 1, 
CHCl3); >99% ee. 
 
(1R,2R,5S)-(-)-ethyl 2',3-dioxo-3'-[(1 S)-1-phenylethyl]-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate 5e and (1S,2S,5R)-(-)-ethyl 
2',3-dioxo-3'-[(1 S)-1-phenylethyl]-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate 5f.  
Epoxide (±)-10 (0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and then (S)-(-)-α-methyl 
benzylamine (0.24 ml, 2.2 mmol) was added. The solution was heated to 70 oC overnight in a 
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sealed tube. The reaction mixture was cooled to RT and concentrated under reduced pressure. 
The residue was purified by SCX cartridge eluting first with MeOH and then with 2.0 M NH3 
in MeOH to yield a mixture of 11e and 11f as a colourless oil. The crude reaction was used 
immediately in the following step. It was dissolved in DMSO (20 ml) and TFA (0.18 ml, 2.3 
mmol) was added followed by IBX (1.85 g, 6.6 mmol). The reaction mixture was stirred at 
RT overnight. Then 5 ml of water were added; after 10 minutes of stirring a white solid was 
filtered. The filtrate was diluted with EtOAc (30 ml), washed with water, dried over MgSO4 
and concentrated. The residue was purified by SCX cartridge eluting first with MeOH and 
then with 2.0 M NH3 in MeOH. The ammonia fractions were further purified by flash 
chromatography on silica gel eluting with 5% MeOH in DCM to yield the ketone (0.4 g, 
53%) as a yellow oil and as a 0.8:1 mixture of diastereoisomers A:B; νmax/cm-1 (CHCl3): 
3328, 2977, 1699, 1432, 1186, 1112, 762; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.36-2.24 
(10 H, m, CHAr A+B), 5.54 (2 H, br s, NCHCH2CO A+B), 4.38-4.10 (6 H, m, NCHC and 
OCH2CH3 A+B), 3.88-3.77 (1 H, q, J = 6.6 Hz, NCHCH3 B), 3.75-3.64 (1 H, q, J = 6.6 Hz, 
NCHCH3 A), 3.25-3.07 (3 H, m, CHCH2CO A+B and CCH2NH B), 3.02 (1 H, d, J = 12.2 
Hz, CCH2NH A), 2.25-2.02 (4 H, m, CHCH2CO A+B and CCH2NH A+B), 2.00-1.77 (4 H, 
m, CHCH2exoCH2exoCH A+B), 1.52-1.41 (2 H, m, CHCH2endoCH2endoCHCH2 A+B), 1.40-1.19 
(14 H, m, NCHCH3 A+B, OCH2CH3 A+B and CHCH2endoCH2endoCHCH2 A+B); 13C NMR δc 
(ppm) (CDCl3, 91 MHz): 209.5 (C, C=Oketone A+B), 155.3 (C, C=Ocarbamate A+B), 145.4 (C, 
CAr A/B), 145.0 (C, CAr A/B), 129.1 (CH, CHAr A/B), 129.0 (CH, CHAr A/B), 127.6 (CH, 
CHAr A/B), 127.5 (CH, CHAr A/B), 127.2 (CH, CHAr A/B), 126.5 (CH, CHAr A/B), 78.5 (C, 
CCH2NH A+B), 61.8 (CH2, OCH2CH3 A+B), 61.2 (CH, NCHC A+B), 59.5 (CH, NCHCH3 
A), 58.6 (CH, NCHCH3 B), 53.8 (CH, NCHCH2CO A/B), 53.6 (CH, NCHCH2CO A/B), 49.3 
(CH2, CCH2NH A), 48.4 (CH2, CCH2NH B), 46.2 (CH2, CHCH2CO A+B), 28.2 (CH2, 
CHCH2CH2CHCH2 A+B), 24.9 (CH3, NCHCH3 A/B), 24.7 (CH3, NCHCH3 A/B), 23.4 (CH2, 
CHCH2CH2CHCH2 A+B), 15.1 (CH3, OCH2CH3 A/B), 15.0 (CH3, OCH2CH3 A/B); m/z 
(ES+) 347 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 347.1976. C19H27N2O4 requires: 
[M+H]+, 347.1971. 
The mixture of ketone diastereomers (0.4 g, 1.16 mmol) was dissolved in DCM (20 ml); 
pyridine (1.2 ml, 0.016 mol) was added and the mixture cooled to 0 oC. Triphosgene (0.38 g, 
1.27 mmol) was subsequently added portionwise and the final mixture was stirred at RT for 4 
hours. It was then diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), H2O (20 ml), 
brine (20 ml), dried over MgSO4 and concentrated. The residue was purified by flash 
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chromatography on silica gel eluting with 40% EtOAc in n-hexane to yield the two single 
diastereoisomers 5e and 5f as pale yellow solids.  
Less polar 5e, pale yellow solid (100 mg, 23% of the overall yield); m.p. 91.8-92.4 oC; [α]D20 
-120.0 (c 1, CHCl3); Rt = 5.47 min; νmax/cm-1 (CHCl3) 2981, 1769, 1731, 1713, 1417,1334, 
1220, 1113, 1022, 702; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.41-7.32 (5 H, m, CHAr), 
5.22-5.17 (1 H, q, J = 7.1 Hz, NCHCH3), 4.63 (1 H, br s, NCHCH2CO), 4.58-4.19 (3 H, m, 
NCHC and OCH2CH3), 4.09 (1 H, br d, J = 8.5 Hz, CCH2N), 3.17-3.05 (1 H, m, 
CHCH2axCO), 2.56 (1 H, br d, J = 8.5 Hz, CCH2N), 2.42 (1 H, d, J = 14.9 Hz, CHCH2eqCO), 
2.04-1.98 (2 H, m, CHCH2exoCH2exoCH), 1.66-1.53 (4 H, m, NCHCH3 and 
CHCH2endoCH2endoCHCH2), 1.32-1.27 (3 H, m, OCH2CH3), 1.16-1.14 (1 H, m, 
CHCH2endoCH2endoCHCH2); 1H NMR δH (ppm) (CDCl3, 360 MHz, 55 ºC): 7.40-7.13 (5 H, m, 
CHAr), 5.21-5.15 (1 H, q, J = 7.1 Hz, NCHCH3), 4.67 (1 H, br s, NCHCH2CO), 4.46-4.15 (3 
H, m, NCHC and OCH2CH3), 4.09 (1 H, d, J = 9.0 Hz, CCH2N), 3.13 (1 H, br d, J = 15.0 Hz, 
CHCH2axCO), 2.56 (1 H, d, J = 9.0 Hz, CCH2N), 2.39 (1 H, d, J = 15.0 Hz, CHCH2eqCO), 
2.14-1.88 (2 H, m, CHCH2exoCH2exoCH), 1.61-1.48 (4 H, m, NCHCH3 and 
CHCH2endoCH2endoCHCH2), 1.32-1.27 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.18-1.12 (1 H, m, 
CHCH2endoCH2endoCHCH2);13C NMR δc (ppm) (CDCl3, 91 MHz): 201.0 (C, C=Oketone), 155.0 
(C, C=O), 154.8 (C, C=O), 139.7 (C, CAr), 129.3 (CH, CHAr), 128.5 (CH, CHAr), 127.3 (CH, 
CHAr), 82.8 (C, CCH2N), 62.2 (CH2, OCH2CH3), 60.1 (CH, NCHC), 54.0 (CH, 
NCHCH2CO), 52.0 (CH, NCHCH3), 46.7 (CH2, CHCH2CO), 41.4 (CH2, CCH2N), 27.9 
(CH2, CHCH2CH2CHC), 23.8 (CH2, CHCH2CH2CHC), 16.5 (CH3, NCHCH3), 14.9 (CH3, 
OCH2CH3); m/z (ES+) 373 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 373.1772. 
C20H25N2O5 requires: [M+H]+, 373.1763. Structure and absolute configuration confirmed by 
X-ray of a sample obtained by crystallisation from ether. 
More polar diastereoisomer 5f, pale yellow solid (135 mg, 31% of the overall yield); m.p 
125.0-126.2 oC; [α]D20 -67.0 (c 1, CHCl3); Rt = 5.62 min; νmax /cm-1 (CHCl3): 2980, 1728, 
1752, 1700, 1420,1110, 1022, 752, 701; 1H NMR δΗ (ppm) (CDCl3, 500 MHz): 7.41-7.28 (5 
H, m, CHAr), 5.21-5.13 (1 H, q, J = 7.1 Hz, NCHCH3), 4.77-4.44 (2 H, m, NCHCH2CO and 
NCHC), 4.35-4.14 (2 H, m, OCH2CH3), 3.81 (1 H, br d, J = 9.1 Hz, CCH2N), 3.20-3.01 (1 H, 
m, CHCH2eqCO), 3.00-2.85 (1 H, m, CCH2N), 2.39 (1 H, d, J = 15.7 Hz, CHCH2axCO), 2.17-
1.94 (2 H, m, CHCH2exoCH2exoCH), 1.67-1.49 (4 H, m, NCHCH3 and 
CHCH2endoCH2endoCHCH2), 1.39-1.15 (4 H, m, OCH2CH3 and CHCH2endoCH2endoCHCH2); 1H 
NMR δΗ (ppm) (CDCl3, 360 MHz, 56 ºC): 7.38-7.27 (5 H, m, CHAr), 5.17-5.11 (1 H, q, J = 
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7.1 Hz, NCHCH3), 4.62-4.50 (2 H, m, NCHCH2CO and NCHC), 4.26-4.16 (2 H, m, 
OCH2CH3), 3.81 (1 H, d, J = 8.9 Hz, CCH2N), 3.11 (1 H, br d, J = 14.7 Hz, CHCH2axCO), 
2.90 (1 H, d, J = 8.9 Hz, CCH2N), 2.36 (1 H, d, J = 14.7 Hz, CHCH2eqCO), 2.10-1.96 (2 H, 
m, CHCH2exoCH2exoCH), 1.61-1.52 (4 H, m, NCHCH3 and CHCH2endoCH2endoCHCH2), 1.34-
1.19 (4 H, m, OCH2CH3 and CHCH2endoCH2endoCHCH2); 13C NMR δc (ppm) (CDCl3, 91 
MHz): 200.8 (C, C=Oketone), 155.1 (C, C=O), 154.7 (C, C=O), 139.3 (C, CAr), 129.1 (CH, 
CHAr), 128.4 (CH, CHAr), 127.3 (CH, CHAr), 82.8 (C, CCH2N), 62.3 (CH2, OCH2CH3), 60.3 
(CH, NCHC), 54.0 (CH, NCHCH2CO), 52.2 (CH, NCHCH3), 46.7 (CH2, CHCH2CO), 42.1 
(CH2, CCH2N), 27.9 (CH2, CHCH2CH2CHCH2), 23.9 (CH2, CHCH2CH2CHCH2), 17.3 (CH3, 
NCHCH3), 15.0 (CH3, OCH2CH3); m/z (ES+) 373 ([M+H]+, 100%); m/z (ES+) found: 
[M+H]+, 373.1766. C20H25N2O5 requires: [M+H]+, 373.1763. 
 
(1R*,2R*,5S*)-Ethyl 2',3-dioxo-3'-phenyl-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate (±)-5g and resolution to give 5g and ent-5g. Epoxide (±)-10 
(0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and aniline (0.2 ml, 2.2 mmol) was added. 
The solution was heated to 70 oC overnight in a sealed tube. The reaction mixture was then 
cooled to RT and and concentrated under reduced pressure. The residue was purified by SCX 
cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield (±)-11g as a 
colourless oil (0.7 g, quantitative yield); νmax/cm-1 (CHCl3): 3370, 2978, 1670, 1603, 1438, 
1314, 1115; 1H NMR δΗ (ppm) (CDCl3, 500 MHz): 7.19 (2 H, t, J = 7.9 Hz, CHAr-meta), 6.76 
(1 H, t, J = 7.3 Hz, CHAr-para), 6.71 (2 H, d, J = 7.9, CHAr-orto), 4.45 (1 H, br d, NCHC), 4.36 (1 
H, br s, NCHCH2CHOH), 4.20-4.13 (2 H, m, OCH2CH3), 3.73-3.70 (1 H, dd, J = 11.4 and 
6.0 Hz, CHCH2CHaxOH), 3.49 (1 H, d, J = 12.8 Hz, CCH2NH), 3.20 (1 H, d, J = 12.8 Hz, 
CCH2NH), 1.97-1.89 (3 H, m, CHCH2exoCH2exoCH and CHCH2CHOH), 1.83-1.65 (2 H, m, 
CHCH2CHOH and CHCH2endoCH2endoCH), 1.65-1.49 (1 H, m, CHCH2endoCH2endoCH), 1.27 
(3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 155.5 (C, 
C=Ocarbamate), 148.7 (C, CAr), 129.7 (CH, CHAr-meta), 118.9 (CH, CHAr-para), 114.4 (CH, CHAr-
orto), 75.3 (C, CCH2NH), 67.5 (CH, CHCH2CHOH), 61.5 (CH2, OCH2CH3), 58.8 (CH, 
NCHC), 52.7 (CH, NCHCH2CHOH), 48.0 (CH2, CCH2NH), 37.2 (CH2, CHCH2CHOH), 
27.3 (CH2, CHCH2CH2CHCH2), 24.7 (CH2, CHCH2CH2CHCH2), 14.7 (CH3, OCH2CH3); 
m/z (ES+) 321 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 321.1824. C17H25N2O4 requires: 
[M+H]+, 321.1814. 
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COCl2 (0.21 ml, 2.42 mmol) in DCM (17 ml) was cooled to -60 oC; DMSO (0.34 ml, 4.84 
mmol) in DCM (1 ml) was added at -60 oC and the mixture stirred for 10 minutes. Then 
intermediate (±)-11g (0.7 g, 2.2 mmol) in DCM (2 ml) was added over 5 minutes at -60 oC. 
After 15 minutes stirring at this temperature, Et3N (1.5 ml, 0.011 mol) was added. The 
cooling bath was removed and slowly warmed to RT. Then H2O (3 ml) was added and the 
mixture stirred at RT for 10 minutes. The two phases were then separated; the organic layer 
was dried over Na2SO4 and concentrated. Purification by flash chromatography on silica gel 
eluting with 3% MeOH in DCM yielded a yellow oil that was further purified by SCX 
cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH. The ketone was 
obtained as a pale yellow oil, (550 mg, 79%); νmax/cm-1 (CHCl3): 3381, 2979, 1684, 1603, 
1438, 1112, 748; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.20 (2 H, t, J = 7.6 Hz, CHAr-meta), 
6.78 (1 H, t, J = 7.3 Hz, CHAr-para), 6.73 (2 H, d, J = 7.9, CHAr-orto), 4.63-4.56 (2 H, br m, 
NCHCH2CO and NCHC), 4.26-4.20 (2 H, m, OCH2CH3), 4.01 (1 H, br s, NH), 3.70 (1 H, br 
s, OH), 3.58 (1 H, d, J = 13.4 Hz, CCH2NH), 3.24-3.17 (2 H, m, CCH2NH and CHCH2axCO), 
2.25 (1 H, dd, J = 14.7 and 2.0 Hz, CHCH2eqCO), 2.04-2.01 (2 H, m, CHCH2exoCH2exoCH), 
1.63-1.59 (2 H, m, CHCH2endoCH2endoCH), 1.30 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc 
(ppm) (CDCl3, 91 MHz): 208.1 (C, C=Oketone), 155.8 (C, C=Ocarbamate), 148.8 (C, CAr), 129.7 
(CH, CHAr), 119.0 (CH, CHAr), 114.5 (CH, CHAr), 79.7 (C, CCH2NH), 62.2 (CH2, 
OCH2CH3), 60.5 (CH, NCHC), 54.2 (CH, NCHCH2CO), 46.3 and 46.2 (CH2, CCH2NH and 
CH2, CHCH2CO), 28.4 (CH2, CHCH2CH2CH), 24.0 (CH2, CHCH2CH2CH), 15.1 (CH3, 
OCH2CH3); m/z (ES+) 319 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 319.1650. 
C17H23N2O4 requires: [M+H]+, 319.1658. 
The amino alcohol (0.55 g, 1.73 mmol) was dissolved in DCM (10 ml); pyridine (1.76 ml, 
0.02 mol) was added and the mixture cooled to 0 oC. Triphosgene (0.56 g, 1.90 mmol) was 
subsequently added portionwise and the final mixture was stirred at RT for 4 hours. It was 
then diluted with DCM (20 ml), washed with 0.1 M HCl (10 ml), H2O (20 ml), brine (20 ml), 
dried over MgSO4 and concentrated. The residue was purified by flash chromatography on 
silica gel eluting with 50% EtOAc in n-hexane to yield (±)-5g as a colourless solid (0.39 g, 
66%); m.p.: 169.1-172.4 oC; νmax/cm-1 (CHCl3): 2981, 1759, 1729, 1699, 1403, 1316, 1111, 
757; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.56 (2 H, d, J = 8.1 Hz, CHAr-orto), 7.39 (2 H, t, J 
= 8.1 Hz, CHAr-meta), 7.17 (1 H, t, J = 7.4 Hz, CHAr-para), 4.90-4.60 (3 H, m, NCHCH2CO, 
NCHC and CCH2N), 4.31-4.20 (2 H, m, OCH2CH3), 3.48 (1 H, br d, J = 12.9 Hz, CCH2N), 
3.24-3.20 (1 H, m, CHCH2axCO), 2.51 (1 H, d, J = 20.5 Hz, CHCH2eqCO), 2.14-2.01 (2 H, m, 
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CHCH2exoCH2exoCH), 1.68-1.56 (1 H, m, CHCH2endoCH2endoCHCH2), 1.45-1.33 (4 H, m, 
CHCH2endoCH2endoCHCH2 and OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 200.4 (C, 
C=Oketone), 154.3 (C, C=Ocarbamate), 151.7 (C, C=Ocyclic carbamate), 137.7 (C, CAr), 129.2 (CH, 
CHAr-meta), 124.6 (CH, CHAr-para), 118.3 (CH, CHAr-orto), 81.6 (C, CCH2N), 62.0 (CH2, 
OCH2CH3), 60.0 (CH, NCHC), 53.8 (CH, NCHCH2CO), 46.4 (CH2, CHCH2CO), 46.0 (CH2, 
CCH2N), 27.6 (CH2, CHCH2CH2CHCH2), 25.1 (CH2, CHCH2CH2CHCH2), 14.6 (CH3, 
OCH2CH3); m/z (ES+) 345 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 345.1442. 
C18H21N2O5 requires: [M+H]+, 345.1450. 
The racemic compound was resolved by SFC (Chiralpak AS-H column, 220 nm, 85/15 
CO2/MeOH, 10 ml/min, 35 oC, Outlet P=100 bar): 
ent-5g: enantiomer 1, Rt = 3.32 min; colourless solid, 70 mg, m.p. 162.2-163.4 oC; [α]D20 -
53.5 (c 1, CHCl3); 99% ee. 
5g enantiomer 2, Rt = 4.23 min; colourless solid, 70 mg, m.p. 163.8-164.2 oC [α]D20 +46.5 (c 
1, CHCl3); 98% ee. 
 
(1R*,2R*,3S*,5S*)-Ethyl 3-hydroxy-5'-oxodihydro-3'H,8-azaspiro[bicyclo[3.2.1]octane-
2,2'-furan]-8-carboxylate (±)-12. Epoxy alcohol  (±)-10 (0.8 g, 3.5 mmol) was dissolved in 
DCM (30 ml) and cooled to -78 oC. Et3N (2.45 ml, 18 mmol) was added followed by 
TMSOTf (1.6 ml, 8.8 mmol). After stirring at this temperature for 30 min, the reaction 
mixture was slowly warmed to -30 oC and stirred at this temperature for further 30 min. It 
was then quenched with a saturated solution of NH4Cl (10 ml). The organic layer was washed 
with brine, dried and concentrated under vacuum. The crude trimethylsilyl ether, as a 
colourless oil, was used in the following step without further purification. 
NaH (60% dispersed in mineral oil, 87 mg, 2.2 mmol) was suspended in THF (10 ml) and 
cooled to 0 oC. Diethyl malonate (0.33 ml, 2.2 mmol) in THF (1 ml) was added dropwise and 
the reaction mixture was stirred at 0 oC for 30 minutes. The silyl ether (540 mg, 1.8 mmol) in 
THF (2 ml) was added dropwise and then the mixture heated to reflux for 3 hours. The 
volatiles were evaporated under reduced pressure to give a mixture of diastereomers. This 
mixture (250 mg) was dissolved in DMSO (5 ml) and water added (0.5 ml) followed by NaCl 
(56 mg). The mixture was heated to 160 oC for 7 h. After this period of time the mixture was 
cooled to room temperature and partitioned between DCM and water. The organic layer was 
washed with brine, dried and concentrated. Purification by chromatography on silica gel 
eluting with a gradient from 50% to 100% ethyl acetate in cyclohexane afforded (±)-12 as a 
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colourless oil (170 mg, 35% over two steps); νmax/cm-1 (film): 3440, 1772, 1684, 1437, 1336, 
1385, 1217, 1111, 964, 772; 1H NMR δH (ppm) (CDCl3, 400 MHz): 4.46-4.32 (1 H, br s, 
NCHCH2CHOH), 4.27-4.02 (3 H, m, NCHC and OCH2CH3), 3.73 (1 H, dd, J=11.24 and 6.06 
Hz, CHOH), 2.79-2.53 (2 H, m, CCH2CH2), 2.51-2.09 (2 H, m, CCH2CH2 and CHOH), 2.08-
1.75 (5 H, m, CHCH2exoCH2exoCH, CCH2CH2, and CHCH2CHOH), 1.70-1.53 (2 H, m, 
CHCH2endoCH2endoCH), 1.32-1.16 (3 H, m, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 
176.4 (C, C=Olactone), 154.2 (C, C=Ocarbamate), 87.9 (C, CCH2CH2), 68.1 (CH, CHCH2CHOH), 
61.3 (CH2, OCH2CH3), 59.3 (CH, NCHC), 52.3 (CH, NCHCH2CHOH), 37.6 (CH2, 
CHCH2CHOH), 28.8 (CH2, CCH2CH2), 27.1 (CH2, CHCH2CH2CH), 26.5 (CH2, CCH2CH2), 
24.9 (CH2, CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) 270 ([M+H]+ 100%), m/z 
(ES+) found: [M+H]+, 270.1337. C13H20NO5 requires: [M+H]+, 270.1341. 
 
(1R*,2R*,5S*)-Ethyl 3,5'-dioxodihydro-3'H,8H-spiro[8-azabicyclo[3.2.1]octane-2,2'-
3furan]-8-carboxylate (±)-6, and resolution to give 6 and ent-6. Lactone (±)-12 (170 mg, 
0.63 mmol) was dissolved in DCM (5 ml). NMO (111 mg, 0.95 mmol) was added followed 
by TPAP (10 mg). The reaction mixture was stirred at RT for 3 h and then was filtered 
through a pad of Celite™. The solvent was removed under reduced pressure and the residue 
was purified by chromatography on silica gel eluting with a gradient from 30 to 80% ethyl 
acetate in cyclohexane to yield (±)-6 as a colorless solid (90 mg, 53%);m.p.: 111.5-112.5 oC; 
νmax/cm-1 (nujol): 1795, 1724, 1694, 1113, 1016, 956, 932, 769; 1H NMR δΗ (ppm) (CDCl3, 
400 MHz): 4.74-4.40 (2 H, m, NCHCH2CO and NCHC), 4.35-4.14 (2 H, m, OCH2CH3), 
3.23-2.98 (1 H, m, CHCH2axCO), 2.92-2.80 (1 H, m, CCH2CH2), 2.78-2.59 (2 H, m, 
CCH2CH2), 2.46 (1 H, d, J = 16.0 Hz, CHCH2eqCO), 2.23-1.99 (2 H, m, 
CHCH2exoCH2exoCH), 1.86-1.71 (1 H, m, CCH2CH2), 1.67-1.57 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.54-1.42 (1 H, m, CHCH2endoCH2endoCHCH2), 1.31 (3 H, t, J = 
7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 100 MHz): 202.3 (C, C=Oketone), 174.4 (C, 
C=Olactone), 154.2 (C, C=Ocarbamate), 88.8 (C, CCH2CH2), 61.8 (CH2, OCH2CH3), 60.4 (CH, 
NCHC), 53.5 (CH, NCHCH2CO), 46.4 (CH2, CHCH2CO), 28.5 (CH2, CCH2CH2), 27.6 (CH2, 
CHCH2CH2CH), 23.6 and 23.4 (CH2, CCH2CH2 and CHCH2CH2CH), 14.6 (CH3, 
OCH2CH3); m/z (ES+) 268 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 268.1172. 
C13H18NO5 requires: [M+H]+, 268.1185. 
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Racemate resolved by semi-preparative chiral chromatography (column: Chiralpak AD-H (25 
x 2.0 cm); mobile phase: n-hexane/ethanol 70/30 % v/v; flow rate: 14.0 ml/min; DAD: 225 
nm). 
ent-6: enantiomer 1: Rt: 18.75 min; 32 mg, colourless solid, m.p.145.9-146.7 oC; [α]D20 
+25.0 (c 0.16, CH3OH); 100% ee.  
6: enantiomer 2: Rt: 22.15 min; 32 mg, colourless solid, m.p.: 145.9-146.7 oC; [α]D20 -33.3 (c 
0.18, CH3OH); 100% ee.  
 
(1R*,2R*,5S*)-Ethyl 3'-methyl-3-oxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,2,3]oxathiazolidine]-8-carboxylate 2',2'-dioxide (±)-14, and resolution to give 14 and 
ent-14. 
Amino alcohol (±)-13 was prepared from (±)-10, via (±)-11a, as described in the procedure 
for the synthesis of 5a.  
Amino alcohol (±)-13 (0.7 g, 2.7 mmol) was dissolved in DCM (20 ml) and cooled to 0 oC. 
Pyridine (2.21 ml, 27 mmol) was added followed by thionyl chloride (0.22 ml, 3 mmol) in 
DCM (1 ml). The reaction mixture was stirred at 0 oC for 30 min and then slowly warmed to 
RT. It was stirred at RT for further 48 h and then quenched by addition of a saturated solution 
of NH4Cl. The organic phase was diluted with DCM (20 ml), washed with a 0.1 M HCl 
solution (20 ml), brine (20 ml), dried over MgSO4 and concentrated. Purification by 
chromatography on silica gel eluting with a gradient from 50% to 100% EtOAc in 
cyclohexane delivered the diastereomeric mixture of cyclic sulfamidites as a colorless solid 
(400 mg, 48%); m/z (ES+) 303 ([M+H]+ 100%); m/z (ES+) found: [M+H]+, 303.1003. 
C12H19N2O5S requires: [M+H]+, 303.1015. This intermediate (400 mg, 1.32 mmol) was 
dissolved in CH3CN (10 ml) and cooled to 0 oC. RuCl3xH2O (catalytic amount) was added 
followed by NaIO4 (420 mg, 1.98 mmol) dissolved in H2O (2 ml). The mixture was stirred at 
RT for 30 min and then partitioned between DCM (20 ml) and H2O (20 ml). The organic 
layer was washed with a saturated solution of NaHCO3 (20 ml), brine (20 ml), dried over 
MgSO4 and concentrated. Purification by chromatography on silica gel eluting with a 
gradient from 50% to 100% ethyl acetate in cyclohexane delivered a solid that was triturated 
with diethyl ether to afford (±)-14 as a colorless solid (230 mg, 55%); m.p.: 127.1-128.2 oC; 
νmax/cm-1 (nujol): 1731, 1689, 1348, 1214, 1178; 1H NMR δH (ppm) (CDCl3, 360 MHz): 
4.79-4.77 (1 H, m, NCHC), 4.68-4.66 (1 H, m, NCHCH2CO), 4.27-4.19 (2 H, m, OCH2CH3), 
4.10 (1 H, d, J = 10.4 Hz, CCH2N), 3.18-3.09 (2 H, m, CCH2N and CHCH2axCO), 2.82 (3 H, 
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s, NCH3), 2.50 (1 H, dd, J = 14.7, 2.1 Hz, CHCH2eqCO), 2.21-1.98 (2 H, m, 
CHCH2exoCH2exoCH), 1.62-1.54 (1 H, m, CHCH2endoCH2endoCHCH2), 1.35-1.27 (4 H, m, 
OCH2CH3 and CHCH2endoCH2endoCHCH2); 13C NMR δc (ppm) (CDCl3, 91 MHz): 199.2 (C, 
C=Oketone), 154.2 (C, C=Ocarbamate), 86.9 (C, CCH2N), 62.4 (CH2, OCH2CH3), 60.2 (CH, 
NCHC), 54.1 (CH, NCHCH2CO), 50.7 (CH2, CCH2N), 46.9 (CH2, CHCH2CO), 35.6 (CH3, 
NCH3), 27.7 (CH2, CHCH2CH2CHCH2), 23.6 (CH2, CHCH2CH2CHCH2), 14.8 (CH3, 
OCH2CH3); m/z (ES+) 319 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 319.0970. 
C12H19N2O6S requires: [M+H]+, 319.0964. 
The racemic mixture (110mg) was resolved by semi preparative chiral chromatography, 
column: Chiralpak AD-H (25 x 0.46 cm); mobile phase: n-hexane/iso-propanol 85/15 % v/v; 
flow rate: 14.0 ml/min; DAD: 225 nm. 
ent-14: enantiomer 1: Rt = 15.23 min; 40 mg, colourless solid, m.p.: 108.3-110.1 oC; [α]D20 
+40.0 (c 0.1, CH3OH); 100% ee. 
14: enantiomer 2: Rt = 18.53 min; 40 mg, colourless solid, m.p.: 113.5-114.8 oC; [α]D20 -40.0 
(c 0.1, CH3OH); 100% ee.  
 
4.3 General procedure for alkene epoxidation13 
To a solution of ketone and alkene (0.1 mmol) in acetonitrile (1.5 ml) was added aqueous 
Na2EDTA solution (1.0 ml of a 0.4 mM aqueous solution). Oxone® (307 mg, 1.0 mmol 
KHSO5) and NaHCO3 (130 mg, 1.55 mmol) were added in portions simultaneously over 30 
minutes. The reaction was stirred vigorously until completion (by TLC analysis) or for 24 
hours, then diluted with water (10 ml). 
Two different work-up procedures (A and B) were employed. Work-up B is highly efficient 
when epoxidation reactions are run in parallel. No difference in the enantioselectivity has 
been observed for examples where both work-up A and work-up B has been used.  
Work-up A (used for Table 1, entries 1, 2, 6, 7, 8; Table 2, entries 2, 4-6; Table 3, entries 1-5; 
Table 4, entries 2, 4-6; Table 5, entries 4, 5, 8; Table 6, entries 2, 4-7): the reaction mixture 
was extracted into diethyl ether (3 × 25 ml). The combined organic extracts were dried 
(Na2SO4), filtered and evaporated to dryness under reduced pressure. Flash column 
chromatography (gradient from 5 to 10% diethyl ether in cyclohexane) on silica or 
purification by preparative thin layer chromatography afforded the relevant epoxide. 
Work-up B (used for Table 1, entries 3, 4, 5, 9-14; Table 2, entries 1, 3, 7; Table 3, entries 6, 
7; Table 4, entries 1, 3, 7, 8; Table 5, entries 1-3, 6, 7, 9; Table 6, entries 1, 3, 6): the reaction 
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mixture was extracted into DCM (25 ml). The organic phase was separated using a phase 
separation cartridge and evaporated to dryness under reduced pressure or under a steam of 
nitrogen. Flash column chromatography (gradient from 5 to 10% diethyl ether in 
cyclohexane) on silica or purification by preparative thin layer chromatography afforded the 
relevant epoxide. 
 
4.4 Determination of epoxide enantiomeric purity 
Epoxides gave 1H NMR data in accord with literature values.7a Epoxide enantiomeric 
excesses were determined by HPLC on chiral stationary phases and the absolute 
configuration of the major products were assigned by comparison with literature retention 
times or optical rotations, as described previously.7a  
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